The ROE as of December 2025 (TTM) for Neurogene Inc. (NGNE) is -29.84%

According to Neurogene Inc.’s latest financial reports and current stock price. The company's current ROE is -29.84%. This represents a change of 297.98% compared to the average of -7.50% of the last 4 quarters.

Neurogene Inc. (NGNE) Historical ROE (quarterly & annually)

How has NGNE ROE performed in the past?

The mean historical ROE of Neurogene Inc. over the last ten years is -15.72%. The current -29.84% ROE has changed 89.80% with respect to the historical average. Over the past ten years (40 quarters), NGNE's ROE was at its highest in in the June 2023 quarter at 7.02%. The ROE was at its lowest in in the September 2019 quarter at -88.42%.

Neurogene Inc. (NGNE) ROE by Quarter and Year

Discovering the peaks and valleys of Neurogene Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neurogene Inc. (NGNE) Average ROE

How has NGNE ROE performed in the past?

The current ROE of Neurogene Inc. (NGNE) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Neurogene Inc. (NGNE) ROE vs. Peers

How is NGNE’s ROE compared to its peers?

Neurogene Inc.’s ROE is greater than Lineage Cell Therapeutics, Inc. (-119.44%), greater than Ocugen, Inc. (-255.25%), greater than Fulcrum Therapeutics, Inc. (-32.17%), greater than Autolus Therapeutics plc (-56.18%), less than ADC Therapeutics S.A. (82.24%), greater than Benitec Biopharma Inc. (-45.91%), greater than Solid Biosciences Inc. (-73.63%), less than PureTech Health plc (12.82%), greater than Quantum-Si incorporated (-47.64%), greater than Alumis Inc. Common Stock (-75.52%),

Build a custom stock screener for Neurogene Inc. (NGNE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurogene Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurogene Inc. (NGNE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurogene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.